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A facile synthesis of six new deoxyﬂuoro querciotls from D-()-quinic acid is described. The key steps
involve the regioselective ﬂuorination as well as highly stereoselective dihydroxylation. These synthetic
deoxyﬂuoro quercitols are considered as potential glycosidase inhibitors.
 2014 Elsevier Ltd. All rights reserved.1. Introduction
Fluorine-containing compounds are widely applied in material1
and medicinal chemistry.1a,2 Evidences have proved that the ﬂuo-
rine substituents drugs can inﬂuence the chemical, physical, and
pharmaceutical properties of molecules.3 The ﬂuorine atom has
comparable size and higher electronegativity than oxygen atom.
This more electrostatic character of the CeF bond leads to high
polarization (large dipole moment) change.4 Also the CeF bond is
a weak hydrogen bonding donor and acceptor.4 This is meaningful
to medicinal chemists for drugs’ designs because the ﬂuorine
substituents may enhance the drug performance and reduce side
effects.2,5 Since the ﬂuorinated molecules are not naturally occur-
ring, however, the demands of ﬂuorinated drugs are increasing
dramatically during the past few years.2a,3 On the other hand,
sugars contained ﬂuorine atom(s) and their analogues are not un-
usual.6 One of the most important sugars’ analogues ismyo-inositol
in which derivatives, phosphatidylinositols, were recognized as
secondary messengers for related cellular modulation.7 In order to
probe the phosphatidylinositol pathway mechanism, a number of
deoxyﬂuoro myo-inositols or their phosphatidyl derivatives were
synthesized.8 In addition, analogues of inositols, so called quercitols
(the generic term for cyclohexanepentols or deoxyinositols) are
considered as potential glycosidase inhibitors.9 We rationalize that
the ﬂuorinated quercitols may play the similar roles asmyo-inositolil.tku.edu.tw (T.-L. Shih).analogues. However, the syntheses of quercitols containing ﬂuorine
atom(s) and their phosphated derivatives are rare.8a,10
We have experienced in syntheses of several candidates of
glycosidase inhibitors, such as azasugars (azepanes)11 and thio-
sugars (thiepanes),12 from D-()-quinic acid. We realized that we
could use D-()-quinic acid as starting material to synthesize a se-
ries of deoxyﬂuoro quercitols. The advantage of our synthesis is to
utilize the rigid conformation of D-()-quinic acid derivatives to
selectively ﬂuorinate the designated conﬁguration of hydroxy
group.
2. Results and discussion
When compound 111c was treated with diethylaminosulfur tri-
ﬂuoride (DAST, 2 equiv),13 the retention conﬁguration product
compound 310a,14 was isolated in 8% yield and an inseparable
mixture of 410a,15 and 516 was obtained in 87% combined yield (ratio
of 4/5 was about 1.72:1 by NMR) (Scheme 1). When compound 3
was subjected to dihydroxylation under RuCl3/NaIO4/NaH2PO4,
compound 6 was isolated as a single product in 40% yield. The
oxidation occurred at the less hindered side, which was anti re-
lationship to the cyclohexylidene group.17,18 While OsO4/NMO10a
was used as oxidants instead, the higher yield of 6 (71%) was re-
ceived. We observed OsO4/NMO is a more reliable method for
dihydroxylation in these cases than RuCl3/NaIO4/NaH2PO4 because
the later gave more unidentiﬁed polar products. The mixture of 4
and 5 was dihydroxylated (OsO4/NMO) to afford a mixture of diol
products in about 74% yield, which could not be separated by ﬂash
Scheme 1. Regioselective syntheses of deoxyﬂuoro quercitols 9e11.
T.-L. Shih et al. / Tetrahedron 70 (2014) 9621e96279622column chromatography. Therefore, the above mixture was further
treated with 2,2-dimethoxypropane with catalytic amount of pyr-
idinium p-toluenesulfonate (PPTS) to yield 719 (40%) and 820 (22%)
(two steps), respectively. This protecting step is not only to allow us
for easy separation of the stereoisomers 7 and 8 but also to conﬁrm
their structures. No other possible diastereoisomers 12e14 were
isolated from reaction might be due to small quantities (Fig. 1). In
order for comparison, compound 2,11c the epimer of 1, was ﬂuori-
nated by the samemanner as 1 to yield 3 in 8%. Again, amixture of 4
and 5 from 2 was obtained with almost equivalent yield in 84%
(ratio of 4/5 was about 1.24:1 by NMR) comparing from 1. There-
fore, compound 4 was obtained as the major product no matter
starting from 1 or 2.Fig. 1. Possible stereoisomers not isolated from reaction.A TMB protected 1518 was ﬂuorinated by the same manner as in
Scheme 1 to afford 1621 (8%) and an inseparable mixture contained
predominately 17 and 18 in about 77% combined yield (ratio was
not determined)22 (Scheme 2). Again, compound 16 was subjected
to dihydroxylation by different oxidants to give 19.23 However, theyield from OsO4/NMO condition (35%) is almost equivalent to
RuCl3/NaIO4/NaH2PO4 (34%). A mixture of 17 and 18 was dihy-
droxylated by either OsO4/NMO or RuCl3/NaIO4/NaH2PO4 to yield
compound 2024 in 33% and 30%, respectively, both along with
a complicated mixture. This mixture then further treated with 2,2-
dimethoxypropane and a catalytic amount of PPTS to yield 2125 (8%,
two steps) as well as a trace amount of unidentiﬁed mixture. We
may not rule out the possibility in formation of stereoisomers
25e29, but we were not able to isolate neither of them throughout
the reaction media (Fig. 2). We are also aware that the stereo-
chemistry of ﬂuoride inﬂuenced the dihydroxylation outcomes.
Dihydroxylation preferentially occurred against the stereochemis-
try of ﬂuoride. A similar case has been reported.18 We found both
oxidation conditions (OsO4/NMO vs RuCl3/NaIO4/NaH2PO4) for
dihydroxylation in Scheme 2 gave lower yields at this stage. It
might be compounds 16e18 were labile under these conditions.
Finally, compounds 6e8 and 19e21were deprotected by using 80%
TFA to obtain 926 (78%), 1027 (90%), 1128 (82%), 22 (88%), 23 (94%),
and 24 (91%) in high yields, respectively. The stereochemistry of
compounds 9e11 and 22e24 has been conﬁrmed by NMR experi-
ments (COSY, NOESY, HMQC, and HMBC) and HRMS.
We deduced the plausible mechanisms based on the formation
of compounds 3e5 and 16e18 in Figs. 3 and 4, respectively.29 Ap-
parently, compounds 3e5might obtain from a combination of SN1,
SN2, and SN20 mechanisms (Fig. 3). Obviously, the formation of 3
from ﬂuorination of 1 must derive from SN1 mechanism (Fig. 3a).
However, both SN1 and SN2 mechanisms were involved to produce
3 from 2 (Fig. 3b). The least hindered compound 4 was obtained as
the major product from either 1 or 2. A slightly high ratio yield
obtained from 1 was probably because both SN2 and SN1 mecha-
nisms were involved simultaneously. However, only SN1
Scheme 2. Regioselective syntheses of deoxyﬂuoro quercitols 22e24.
Fig. 2. Possible stereoisomers not isolated from reaction.
T.-L. Shih et al. / Tetrahedron 70 (2014) 9621e9627 9623mechanism participated in formation of 4 from 2 (Fig. 3a). The path
d in both cases likely does not occurre due to the steric effect
(Fig. 3a). Compound 15 could possibly involve both SN2 and SN20
mechanisms to afford 17 and a mixture of 16/18, respectively
(Fig. 4). Since no epimer of 17 was received, we could possibly as-
sume that the SN1 mechanism might not involve in ﬂuorination of
15.
3. Conclusion
In conclusion, we have accomplished the synthesis of six new
deoxyﬂuoro quercitols 9e11 and 22e24 from D-()-quinic acid
with a facile manner. The regioselectivity of ﬂuorination of 1,2 and
15 is not high, however, the total yields are high. Dihydroxylation of
compounds 3e5 and 16e18 using OsO4/NMO was a more reliable
and highly diastereoselective method in accordance with ourprevious report.18 These molecules will be evaluated as glycosidase
inhibitors and published in due course.
4. Experimental section
4.1. General
All chemicals were purchased from commercial providers and
used without further puriﬁcation except otherwise stated. Melting
points were uncorrected. 1H (600 MHz) and 13C NMR (150 MHz)
spectra were recorded on a Bruker 600 instrument. Chemical shifts
were reported in parts per million (ppm) and referenced to the
residual of solvents as following: CD3OD (3.34 ppm for 1H;
49.0 ppm for 13C); D2O (4.63 ppm for 1H). Flash column chroma-
tography all performed on 230e400 mesh silica gel except other-
wise mentioned. Reactions were monitored in progress by thin
Fig. 3. The plausible mechanisms in ﬂuorination of 1 and 2.
Fig. 4. The plausible mechanisms in ﬂuorination of 15.
T.-L. Shih et al. / Tetrahedron 70 (2014) 9621e96279624layer chromatography (TLC). Optical rotations were measured by
Horbia Sepa-300 instrument at 23 C. The LRMS and HRMS data
were measured by the National Taiwan University, the National
Tsing Hua University, and the National Chung Hsing University.
4.2. General procedure of ﬂuorination
Compound 1 (2.087 g, 9.93 mmol) in CH2Cl2 (100 mL), for ex-
ample, was added DAST (2.62mL,19.86mmol) at 0 C and gradually
warmed up to ambient temperature then stirred for 24 h. At the end
of reaction time, the mixture was diluted with saturated NaHCO3,
extracted with CH2Cl2, and dried (MgSO4). Flash column chroma-
tography (pentane/ether¼25:1) provided 3 (0.178 g, 8%) and
amixture of 4 and 5 (1.823 g, 87%). It is noteworthy that compounds
3e5 as well as compounds 16e18 are slightly volatile under re-
duced pressure and handle with care (400e500 bar, 40 C water
bath).4.3. General procedure of dihydroxylation
Compound 3 (49 mg, 0.231 mmol), for example, was dissolved
in acetone/H2O (7.5 mL:2.5 mL) and treated with OsO4 (0.12 mL,
prepared in 0.1 M in THF) and NMO (81.2 mg, 0.693 mmol) se-
quentially at ambient temperature. This mixture was stirred at that
temperature for 12 h and monitored by TLC. The reaction was
quenched by addition of saturated solution of Na2S2O3 and stirred
for 3 h. Acetone was removed, diluted with EtOAc, dried over
MgSO4, ﬁltered, concentrated, and puriﬁed by ﬂash column chro-
matography (Hex/EtOAc¼3:1 to 1:1) to afford 6 (40.2 mg,
0.163 mmol, 71%).
4.4. General procedure of deprotection
Compound 6 (47 mg, 0.191 mmol), for example, was treated
with 80% TFA (8 mL) and stirred at ambient temperature until
T.-L. Shih et al. / Tetrahedron 70 (2014) 9621e9627 9625reaction completed by TLC indication (w1 h). The solvent was re-
moved under reduced pressure. The residue was puriﬁed by ﬂash
column chromatography (Hex/EtOAc¼3:1 to 1:1) to afford 9
(24.9 mg, 0.15 mmol, 78%).
4.5. (1R,2R,3S,4S,5S)-1,2-O-Cyclohexylidene-5-
ﬂuorocyclohexane-1,2,3,4-tetraol (6)
Compound 3 (49 mg, 0.231 mmol) was dihydroxylated and
puriﬁed by ﬂash column chromatography (Hex/EtOAc¼3:1 to 1:1)
to afford 6 (40.2 mg, 0.163 mmol, 71%) as a white solid.
Mp¼77e78 C. [a]D 22.3 (c 0.52, MeOH). 1H NMR (CD3OD) d 4.67
(ddt, J¼50.0, 11.0, 5.3 Hz, H5), 4.37 (dd, J¼8.7, 4.2 Hz, H1), 4.14 (t,
J¼5.2 Hz, H2), 3.96 (ddd, J¼13.0, 6.4, 2.8 Hz, H4), 3.90 (dd, J¼7.3,
3.9 Hz, H3), 2.32 (ddt, J¼28.8, 15.3, 5.3 Hz, H6eq), 2.07 (ddt, J¼23.8,
15.3, 4.7 Hz, H6axial),1.68e1.62 (m, 4H),1.60e1.54 (m, 4H),1.43e1.38
(m, 2H). 13C NMR (CD3OD) d 110.5, 92.2 (1JCeF¼172.5 Hz, C5), 78.7
(C2), 73.1 (3JCeF¼3 Hz, C1), 72.3 (2JCeF¼22.5 Hz, C4), 72.0
(3JCeF¼7.5 Hz, C3), 38.9, 35.6, 32.0 (2JCeF¼19.5 Hz, C6), 26.4, 25.2,
24.9. HRMS (ESI) calcd for C12H20FO4 [MþH]þ 247.1346. Found:
247.1376.
4.6. (1R,2R,3S,4S,5S)-1,2-O-Cyclohexylidene-3,4-O-iso-
propylidene-5-ﬂuorocyclohexane-1,2,3,4-tetraol (7)
Compounds 4þ5 (0.460 g, 2.17 mmol) were dihydroxylated then
treated with 2,2-dimethoxypropane (0.99 mL, 8.06 mmol) and
PPTS (0.0201 g, 0.081 mmol) in CH2Cl2 (15 mL). Flash column
chromatography (Hex/EtOAc¼30:1 to 20:1) afforded 7 (0.248 g,
0.86 mmol) as a pale-yellow syrup. Yield¼40% (two steps). [a]D
þ77.3 (c 0.54, MeOH). 1H NMR (C6D6) d 4.94 (ddt, J¼46.5, 11.9,
2.8 Hz, H5), 4.43 (d, J¼7.6 Hz, H3), 4.30e4.24 (m, H2,4), 4.20e4.19 (m,
H1), 2.21 (tt, J¼9.2, 3.7 Hz, H6eq), 1.91 (t, J¼13.4 Hz, H6axial),
1.59e1.53 (m, 4H), 1.46e1.37 (m, 7H), 1.22e1.21 (m, 2H), 1.10 (s, 3H).
13C NMR (C6D6) d 109.1, 108.6, 86.7 (1JCeF¼178.5 Hz, C5), 76.2
(3JCeF¼6 Hz, C3), 73.3 (2JCeF¼15 Hz, C4), 72.9 (C2), 72.8 (3JCeF¼6 Hz,
C1), 36.8, 33.5, 29.0 (2JCeF¼19.5 Hz, C6), 26.2, 25.9, 24.7, 24.2, 23.9.
HRMS (ESI) calcd for C15H23FNaO4 [MþNa]þ 309.1478. Found:
309.1466.
4.7. (1R,2R,4R,5R)-1,2-O-Cyclohexylidene-1,2-O-iso-
propylidene-3-ﬂuorocyclohexane-1,2,4,5-tetraol (8)
A mixture of compounds 4 and 5 (0.460 g, 2.17 mmol). Flash
column chromatography (Hex/EtOAc¼30:1 to 20:1) afforded 8
(0.138 g, 0.48 mmol) as a pale-yellow syrup. Yield¼22% (two steps).
[a]D 47.0 (c 0.56, MeOH). 1H NMR (C6D6) d 4.46 (ddd, J¼44.5, 5.9,
2.8 Hz, H3), 4.45 (dd, J¼10.7, 7.4 Hz, H4), 4.35 (dt, J¼7.7, 4.4 Hz, H5),
4.21 (ddd, J¼16.8, 7.6, 2.2 Hz, H2), 4.08 (dt, J¼9.2, 4.8 Hz, H1), 2.07
(dt, J¼14.2, 4.7 Hz, H6eq), 1.69e1.57 (m, 4HþH6axial), 1.47e1.40 (m,
7H), 1.24e1.20 (m, 2H), 1.13 (s, 3H). 13C NMR (C6D6) d 109.8, 109.1,
91.8 (1JCeF¼180 Hz, C3), 74.2 (2JCeF¼24 Hz, C4), 73.6 (2JCeF¼16.5 Hz,
C2), 72.2 (3JCeF¼4.5 Hz, C1), 71.7 (3JCeF¼4.5 Hz, C5), 37.5, 33.9, 31.2
(C6), 26.6, 25.9, 24.7, 24.3, 24.2. HRMS (ESI) calcd for C15H23FNaO4
[MþNa]þ 309.1478. Found: 309.1465.
4.8. (1R,2R,3S,4S,5S)-5-Fluorocyclohexane-1,2,3,4-tetraol (9)
Compound 6 (47 mg, 0.191 mmol). Puriﬁcation by ﬂash column
chromatography (Hex/EtOAc¼1:1 to 0:1) afforded 9 (24.9 mg,
0.15 mmol) as a white solid. Yield¼78%. Mp¼186e187 C. [a]D
94.0 (c 0.52, MeOH). 1H NMR (D2O) d 4.64e4.56 (m, signals
overlapped with HOD, H5), 4.00e3.95 (m, H1,3), 3.91e3.85 (m, H2,4),
2.12 (tt, J¼13.6, 4.3 Hz, H6eq), 1.88 (dt, J¼22.5, 11.2 Hz, H6axial). 13C
NMR (D2O) d 90.3 (1JCeF¼169.5 Hz, C5), 71.3, 70.5, 70.4, 65.9, 31.4
(2JCeF¼18 Hz, C6). 1H NMR (CD3OD) d 4.63e4.51 (m, signalsoverlapped with HOD, H5), 3.97e3.92 (m, H1þ2). 3.84e3.80 (m,
H3þ4), 2.06 (ddd, J¼17.0, 9.4, 4.9, H6eq), 1.91 (dt, J¼22.6, 14.6, Hz,
H6axial). 13C NMR (150MHz, CD3OD) d 92.0 (1JceF¼173.5 Hz, C5), 74.0
(3JCeF¼7.5 Hz, C1), 73.7, 72.4 (3JCeF¼18 Hz, C3), 67.3 (2JCeF¼12.0 Hz,
C4), 34.0 (2JCeF¼18 Hz, C6). HRMS (ESI) calcd for C7H12FO6
[MþHCO2]þ 211.0618. Found: 211.0666.
4.9. (1R,2R,3S,4S,5R)-5-Fluorocyclohexane-1,2,3,4-tetraol (10)
Compound 7 (52 mg, 0.182 mmol). Puriﬁcation by column
chromatography (Hex/EtOAc¼3:1 to 0:1) afforded 10 (26.6 mg,
0.16 mmol) as a white solid. Yield¼88%. Mp¼171e172 C. [a]D
52.3 (c 0.51, MeOH). 1H NMR (D2O) d 4.78 (ddt, J¼46.7, 8.0, 2.7 Hz,
H5), 4.10 (d, J¼10.9 Hz, H4), 3.99 (t, J¼3.2 Hz, H1), 3.67 (s, H2,3),
1.98e1.94 (m, H6eqþ6axial). 13C NMR (D2O) d 89.2 (1JCeF¼186 Hz, C5),
70.5 (C2þ4), 69.4 (C3), 66.8 (C1), 30.3 (2JCeF¼20 Hz, C6). HRMS (ESI)
calcd for C6H12FO6 [MþH]þ 167.0720. Found: 167.0708.
4.10. (1R,2R,4R,5R)-3-Fluorocyclohexane-1,2,4,5-tetraol (11)
Compound 8 (21 mg, 0.073 mmol). Flash column chromatog-
raphy (Hex/EtOAc¼3:1 to 0:1) afforded 11 (10.1 mg, 0.061 mmol) as
a white solid. Yield¼82%. Mp¼163e164 C. [a]D 40.7 (c 0.29,
MeOH). 1H NMR (D2O) d 4.51 (ddd, J¼48.2, 9.8, 2.9 Hz, H3), 4.16 (d,
J¼10.2 Hz, H4), 3.98 (dt, J¼9.6, 3.2 Hz, H1), 3.92e3.88 (m, H5), 3.86
(dt, J¼10.3, 3.2 Hz, H2), 1.80e1.74 (m, H60eqþ6axial). 13C NMR (D2O)
d 91.8 (1JCeF¼177 Hz, C3), 70.8 (C4), 68.9 (2JCeF¼18 Hz, C2), 67.5 (C1),
65.1 (C5), 32.0 (C6). HRMS (ESI) calcd for C6H10FO4 [MH]þ
165.0563. Found: 165.0558.
4.11. (1R,2S,3R)-1,2-O-[(2S,3S)-2,3-Dimethoxybutane-
2,3-dioxy]-3-ﬂuorocyclohex-4-ene (16)
Compound 15 (1.950 g, 7.987 mmol). Flash column chroma-
tography (pentane/Et2O¼30:1 to 20:1) afforded 16 (0.163 g,
0.663 mmol) as a pale-yellow solid. Yield¼8%. [a]D þ39.7 (c 0.51,
MeOH). 1H NMR (C6D6) d 5.56e5.52 (m, H5), 5.47e5.42 (m, H4), 4.78
(ddd, J¼52.1, 4.9, 3.6 Hz, H3), 4.32 (dt, J¼14.7,10.5 Hz, H1), 3.65 (ddd,
J¼23.6, 10.9, 3.3 Hz, H2), 3.06 (s, 3H), 3.05 (s, 3H), 2.19 (ddd, J¼23.9,
11.9, 6.1 Hz, H6eq), 2.08e1.96 (m, H6axial), 1.40 (s, 3H),1.33 (s, 3H). 13C
NMR (C6D6) d 132.9 (3JCeF¼9 Hz, C5), 124.2 (2JCeF¼15 Hz, C4), 100.6,
99.8, 85.3 (1JCeF¼176 Hz, C3), 71.0 (2JCeF¼18 Hz, C2), 63.4, 48.0, 47.9,
32.1 (C6), 18.5, 18.4. HRMS (ESI) calcd for C12H19FNaO4 [MþNa]þ
269.1165. Found: 269.1152.
4.12. (1R,2S,3S,4S,5S)-1,2-O-[(2S,3S)-2,3-Dimethoxybutane-
2,3-dioxy]-3-ﬂuorocyclohexane-1,2,4,5-tetraol (19)
Compound 16 (25.2 mg, 0.102 mmol). Flash column chroma-
tography (Hex/EtOAc¼3:1 to 1:1) afforded 19 (21 mg, 0.074 mmol)
as a white solid. Yield¼72%. Mp¼172e173 C. [a]D þ125.3 (c 0.33,
MeOH). 1H NMR (CD3OD) d 4.63 (dd, J¼50.4, 2.3 Hz, H3), 4.57 (s,
eOH), 3.99 (dd, J¼7.3, 3.7 Hz, H2), 3.88e3.78 (m, H1,4,5), 3.22 (s, 6H),
1.86e1.75 (m, H6eqþ6axial),1.29 (s, 3H),1.24 (s, 3H). 13C NMR (CD3OD)
d 101.7, 100.7, 92.7 (1JCeF¼177 Hz, C3), 71.4 (2JCeF¼25.5 Hz, C2), 70.3
(2JCeF¼15 Hz, C4), 67.8 (C5), 64.8 (3JCeF¼3 Hz, C1), 48.3 (2), 32.9
(C6), 18.2, 18.1. HRMS (ESI) calcd for C12H20FO6 [MH]þ 279.1244.
Found: 279.1238.
4.13. (1R,2S,3R,4R,5R)-1,2-O-[(2S,3S)-2,3-Dimethoxybutane-
2,3-dioxy]-5-ﬂuorocyclohexane-1,2,3,4-tetraol (20)
A mixture of compounds 17 and 18 (1.490 g, 6.054 mmol). Flash
column chromatography (Hex/EtOAc¼3:1 to 1:2) afforded 20
(0.558 g,1.993mmol) as awhite solid. Yield¼33%. Mp¼196e197 C.
[a]D þ175.0 (c 0.51, MeOH). 1H NMR (CD3OD) d 4.73 (dd, J¼45.4,
T.-L. Shih et al. / Tetrahedron 70 (2014) 9621e962796262.6 Hz, H5), 4.00 (dd, J¼7.6, 3.8 Hz, H4), 3.78e3.74 (m, H1,2), 3.64 (dd,
J¼6.7, 2.9 Hz, H3), 3.27 (s, 3H), 3.21 (s, 3H), 2.10e1.82 (m,
H6eqþ6axial), 1.28 (s, 3H), 1.25 (s, 3H). 13C NMR (CD3OD) d 101.0, 91.8
(1JCeF¼171 Hz, C5), 72.3 (C1), 71.6 (2JCeF¼27 Hz, C4), 70.2 (C3), 66.5
(C2), 48.4, 48.2, 30.8 (2JCeF¼19.5 Hz, C6), 18.2 (x2). HRMS (ESI) calcd
for C12H20FO6 [MH]þ 279.1244. Found: 279.1238.
4.14. (1R,2S,3R,4R,5R)-1,2-O-[(2S,3S)-2,3-Dimethoxybutane-
2,3-dioxy]-3-ﬂuorocyclohexane-1,2,4,5-tetraol (21)
A mixture of compounds 17 and 18 (1.490 g, 6.054 mmol). Flash
column chromatography (Hex/EtOAc¼30:1 to 1:10) afforded 21
(0.114 g, 0.357 mmol) as a white solid. Yield¼6% (two steps).
Mp¼117e118 C. [a]D þ102.3 (c 0.50, MeOH). 1H NMR (D2O) d 4.80
(ddd, J¼52.5, 10.1, 6.5 Hz, H3), 4.06 (dt, J¼15.5, 4.7 Hz, H1), 3.87 (dt,
J¼21.2, 6.1 Hz, H4), 3.78 (s, H5), 3.66 (dd, J¼21.0, 10.4 Hz, H2), 3.19 (s,
3H), 3.00 (s, 3H), 2.22 (dd, J¼14.7, 4.7 Hz, H6eq), 1.50 (ddd, J¼18.6,
12.4, 4.0 Hz, H6axial), 1.36 (s, 3H), 1.30 (s, 3H), 1.22 (s, 3H), 1.14 (s, 3H).
13C NMR (D2O) d 109.7, 99.9, 99.8, 95.4 (1JCeF¼183 Hz, C3), 79.3
(2JCeF¼21 Hz, C4), 73.7 (3JCeF¼10.5 Hz, C5), 71.8 (2JCeF¼16.5 Hz, C2),
64.3 (3JCeF¼7.5 Hz, C1), 48.1, 48.0, 29.9 (C6), 28.3, 26.4, 18.3, 18.2.
HRMS (ESI) calcd for C15H25FNaO6 [M]þ 343.1533. Found: 343.1527.
4.15. (1R,2S,3S,4S,5S)-3-Fluorocyclohexane-1,2,4,5-tetraol (22)
Compound 19 (32 mg, 0.114 mmol). Puriﬁcation by ﬂash column
chromatography (Hex/EtOAc¼1:2 to 0:1) afforded 22 (16.7 mg,
0.101 mmol) as a white solid. Yield¼88%. Mp¼215e216 C. [a]D
42.7 (c 0.25, MeOH). 1H NMR (D2O) d 4.73e4.60 (m, H3), 3.99 (dd,
J¼7.6, 4.1 Hz, H2), 3.87 (ddd, J¼11.0, 7.4, 3.7 Hz, H1), 3.73e3.65 (m,
H5), 3.67e3.59 (m, H4), 1.90 (dt, J¼12.4, 4.2 Hz, H6eq), 1.62 (dd,
J¼22.5, 11.2 Hz, H6axial). 13C NMR (D2O) d 92.5 (1JCeF¼172.5 Hz, C3),
71.3 (2JCeF¼16.5 Hz, C4), 69.2 (2JCeF¼25.5 Hz, C2), 67.6 (C5), 66.3 (C1),
33.2 (C6). HRMS (ESI) calcd for C6H11FNaO4 [MþNa]þ 189.0539.
Found: 189.0533.
4.16. (1R,2S,3R,4R,5R)-5-Fluorocyclohexane-1,2,3,4-tetraol (23)
Compound 20 (40mg, 0.143mmol). Puriﬁcation by ﬂash column
chromatography (Hex/EtOAc¼1:2 to 0:1) afforded 23 (22.3 mg,
0.134 mmol) as a white solid. Yield¼94%. Mp¼177e178 C. [a]D
þ23.7 (c 0.51, MeOH). 1H NMR (D2O) d 4.71 (ddd, J¼45.4, 6.4, 3.7 Hz,
H5), 3.99 (dd, J¼7.4, 3.6 Hz, H4), 3.58 (ddd, J¼11.6, 9.4, 4.9 Hz, H1),
3.53 (ddd, J¼9.7, 3.2 Hz, H3), 3.44 (t, J¼9.5 Hz, H2), 2.15e2.08 (m,
H6eq), 1.88 (dddd, J¼47.5, 14.3, 11.6, 2.2 Hz, H6axial). 13C NMR (D2O)
d 90.3 (1JCeF¼167 Hz, C5), 74.0 (C2), 70.8 (C3), 69.5 (2JCeF¼27 Hz, C4),
68.5 (C1), 32.0 (2JCeF¼20 Hz, C6). HRMS (ESI) calcd for C6H11FNaO4
[MþNa]þ 189.0539. Found: 189.0534.
4.17. (1R,2S,3R,4R,5R)-3-Fluorocyclohexane-1,2,4,5-tetraol (24)
Compound 21 (35mg, 0.109mmol). Puriﬁcation by ﬂash column
chromatography (Hex/EtOAc¼1:2 to 0:1) afforded 24 (16.4 mg,
0.099 mmol) as a white solid. Yield¼91%. Mp¼219e220 C. [a]D
100.3 (c 0.25, MeOH). 1H NMR (D2O) d 4.33 (dt, J¼53.0, 9.4 Hz, H3),
3.97 (s, H1), 3.73e3.94 (m, H2,5), 3.44 (dt, J¼13.4, 9.3 Hz, H4), 1.99
(dt, J¼14.1, 4.1 Hz, H6eq), 1.46 (td, J¼14.3, 2.2 Hz, H6axial). 13C NMR
(D2O) d 94.9 (1JCeF¼174 Hz, C3), 75.4 (2JCeF¼15 Hz, C4), 72.0
(2JCeF¼16.5 Hz, C2), 68.1 (3JCeF¼10.5 Hz, C1), 67.7 (3JCeF¼9.0 Hz, C5),
34.8 (C6). HRMS (ESI) calcd for C6H11FNaO4 [MþNa]þ 189.0539.
Found: 189.0533.
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